From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA

We’re here to bring you the highlights of what #lungcancer experts have been discussing on the third day of #TTLC24!

Can’t make it? We’ll be covering all the latest here with exclusive interviews and more at 👉 http://VJOncology.com 👈

@VJOncology @IASLC #LCSM #NSCLC #SCLC

It’s day 2 of #TTLC24, and we’re excited to continue coverage of the latest in targeted therapies for #lungcancer!

Follow us @VJOncology or visit http://VJOncology.com for more information.

@IASLC #LCSM #NSCLC #SCLC

💥 Day 1 of #TTLC24 has arrived, so be sure keep an eye out for all the developments in targeted therapies for #lungcancer!

Don’t forget to visit http://vjoncology.com for exclusive interviews with the speakers!

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

We’re here to bring you the highlights of what #lungcancer experts have been discussing on the third day of #TTLC24!

Can’t make it? We’ll be covering all the latest here with exclusive interviews and more at 👉 http://VJOncology.com 👈

@VJOncology @IASLC #LCSM #NSCLC #SCLC

It’s day 2 of #TTLC24, and we’re excited to continue coverage of the latest in targeted therapies for #lungcancer!

Follow us @VJOncology or visit http://VJOncology.com for more information.

@IASLC #LCSM #NSCLC #SCLC

💥 Day 1 of #TTLC24 has arrived, so be sure keep an eye out for all the developments in targeted therapies for #lungcancer!

Don’t forget to visit http://vjoncology.com for exclusive interviews with the speakers!

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More